Skip to content Skip to footer
Elon Musk’s xAI’s Record-Breaking Star-Studded Funding – $TSLA $NVDA $AMD $SPY
Based on reports from Business Insider, Elon Musk's artificial intelligence company xAI has secured a staggering $6 billion…
Eupraxia Pharma’s DiffuSphere Technology Has Shown Promising Results In Pain, Infectious Diseases, Eye Diseases And Cancers
Eupraxia Pharma's (NASDAQ: EPRX) DiffuSphere technology has shown promising results in targeted drug delivery for cancer treatment. The…
Insulin Pump Market Experiencing Innovation Surge – Beta Bionics Upsized IPO – Modular Medical FDA Clearance – $BBNX $MODD
The insulin pump market is experiencing a surge of innovation, with Beta Bionics targeting a $695 million valuation…
Beta Bionics Upsizes IPO On Thursday As Insulin Pump Market Sees Innovation Surge – $BBNX $MODD
Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the pricing…
McDonald’s Flipping The Script To “A Summer Hiring Spree” – $MCD $SPY
McDonald’s (MCD) is flipping the script on summer hiring with its most ambitious recruitment drive in years, announcing…
Will NVIDIA & “Physical AI” Drive The Next Industrial Revolution? – ($NVDA $SPY $QQQ)
At Computex 2025, NVIDIA (NVDA) CEO Jensen Huang unveiled a sweeping vision for "physical AI" – a paradigm…
Key Stock Market Events and Earnings Reports For This Week Of May – $HD $PANW $TGT $TJX $WSM $RL $INTU
This week brings a dense calendar of corporate earnings and economic data releases, each with implications for investors…
Medtronic’s Bold Bet: Spinning Off Diabetes IPO and Eyeing the Next Big Thing – ( $MDT $MODD )
Medtronic’s (MDT) latest earnings report delivered a blend of financial outperformance and strategic intrigue, as the medical device…
World Eosinophilic Esophagitis Day: Shining a Spotlight on EoE and Hope for the Future – ( $EPRX )
May 22, 2025 marks a milestone for patients, families, and clinicians worldwide: the inaugural World Eosinophilic Esophagitis Day…
Your Guide To Staying Informed In The Markets

Subscribe For Free Email Updates Access To Exclusive Research

Vista Partners — © 2026 — Vista Partners LLC (“Vista”) is a Registered Investment Advisor in the State of California. Vista is not licensed as a broker, broker-dealer, market maker, investment banker, or underwriter in any jurisdiction. By viewing this website and all of its pages, you agree to our terms. Read the full disclaimer here